From SEDAR:
2319634.2
Form 51–102F3
Material Change Report
Item 1 Name and Address of Company
Tekmira Pharmaceuticals Corporation
200 - 8900 Glenlyon Parkway
Glenlyon Business Park
Burnaby, B.C.
V5J 5J8
(“Tekmira”)
Item 2 Date of Material Change
May 30, 2008
Item 3 News Release
A press release was issued by Tekmira through Marketwire on June 2, 2008.
Item 4 Summary of Material Change
Tekmira Pharmaceuticals Corporation (“Tekmira”) announced on June 2, 2008 that it had completed the business combination (the “Business Combination”) with Protiva Biotherapeutics
Inc. (“Protiva”).
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM